Company Profile

Abbe Vision Inc (AKA: Powerscope Inc)
Profile last edited on: 5/19/2020      CAGE: 7WPX3      UEI: S6JDKM3A97W3

Business Identifier: Regenerative medicine
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

17862 Steading Road
Eden Prairie, MN 55347
   (612) 616-5441
Location: Single
Congr. District: 03
County: Hennepin

Public Profile

Abbe Vision Inc. is the successor of Powerscope Inc. which was founded by Dr. Amir Naqwi and was in operation from 2001 to 2012. The company has had core competencies in aerosol technology, laser diagnostics and fluid mechanics. Powerscope developed devices for aerosolized drug delivery and drug aerosol characterization, in addition to certain non-medical products. After an acquisition in 2012, Powerscope was deactivated. In July 2017, Dr. Naqwi reactivated the company with the new name Abbe Vision Inc. The company is currently conducting contract research in the area of regenerative medicine and seeking federal grants to expand its operations. ? Abbe Vision’s mission is to leverage core competencies in aerosol technology, laser diagnostics and fluid mechanics to develop and commercialize products and processes for the health and safety of people.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2020 1 NIH $336,954
Project Title: Treatment of Proliferative Vitreoretinopathy Using Aerosolized Methotrexate
2020 1 NIH $274,222
Project Title: Tools for Improved Translation of Novel Inhalable Therapeutics

Key People / Management

  Amir A Naqwi -- President

  Gareth Morris-Stiff -- Clinical Consultant for Oncology and Metabolic Diseases

Company News

There are no news available.